taurine has been researched along with Coronary Disease in 23 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We compared the effect of oral administration of taurine (3 g/day) and coenzyme Q10 (CoQ10) (30 mg/day) in 17 patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, whose ejection fraction assessed by echocardiography was less than 50%." | 9.07 | Usefulness of taurine in chronic congestive heart failure and its prospective application. ( Awata, N; Azuma, J; Sawamura, A, 1992) |
| "In a double-blind, randomized, crossover, placebo-controlled study, we investigated the effects of adding taurine to the conventional treatment in 14 patients with congestive heart failure for a 4-week period." | 9.05 | Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. ( Awata, N; Azuma, J; Hamaguchi, T; Harada, H; Hasegawa, H; Ishiyama, T; Ohta, H; Sawamura, A; Takihara, K; Yamagami, T, 1985) |
| "We conducted a case-control study nested in the New York University Women's Health Study to evaluate the association between circulating taurine levels and risk of coronary heart disease (CHD)." | 7.79 | Serum taurine and risk of coronary heart disease: a prospective, nested case-control study. ( Chen, Y; Costa, M; Koenig, KL; Pearte, C; Wójcik, OP; Zeleniuch-Jacquotte, A, 2013) |
| "To test the hypothesis that endogenous synthesis of taurine from methionine is impaired in people with coronary heart disease (CHD)." | 7.72 | Plasma taurine and cysteine levels following an oral methionine load: relationship with coronary heart disease. ( Emery, PW; Johnston, K; Obeid, OA, 2004) |
| "The loss of mechanical function in rat hearts subjected to either the calcium-paradox or global ischemia heart failure models was found to correlate with decreases in myocardial taurine levels." | 7.66 | Effect of taurine on calcium paradox and ischemic heart failure. ( Chovan, JP; Kramer, JH; Schaffer, SW, 1981) |
| "We compared the effect of oral administration of taurine (3 g/day) and coenzyme Q10 (CoQ10) (30 mg/day) in 17 patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, whose ejection fraction assessed by echocardiography was less than 50%." | 5.07 | Usefulness of taurine in chronic congestive heart failure and its prospective application. ( Awata, N; Azuma, J; Sawamura, A, 1992) |
| "In a double-blind, randomized, crossover, placebo-controlled study, we investigated the effects of adding taurine to the conventional treatment in 14 patients with congestive heart failure for a 4-week period." | 5.05 | Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. ( Awata, N; Azuma, J; Hamaguchi, T; Harada, H; Hasegawa, H; Ishiyama, T; Ohta, H; Sawamura, A; Takihara, K; Yamagami, T, 1985) |
| "We conducted a case-control study nested in the New York University Women's Health Study to evaluate the association between circulating taurine levels and risk of coronary heart disease (CHD)." | 3.79 | Serum taurine and risk of coronary heart disease: a prospective, nested case-control study. ( Chen, Y; Costa, M; Koenig, KL; Pearte, C; Wójcik, OP; Zeleniuch-Jacquotte, A, 2013) |
| "To test the hypothesis that endogenous synthesis of taurine from methionine is impaired in people with coronary heart disease (CHD)." | 3.72 | Plasma taurine and cysteine levels following an oral methionine load: relationship with coronary heart disease. ( Emery, PW; Johnston, K; Obeid, OA, 2004) |
| "The loss of mechanical function in rat hearts subjected to either the calcium-paradox or global ischemia heart failure models was found to correlate with decreases in myocardial taurine levels." | 3.66 | Effect of taurine on calcium paradox and ischemic heart failure. ( Chovan, JP; Kramer, JH; Schaffer, SW, 1981) |
| "Taurine has anti-atherosclerotic activity in animal models, possibly reflecting a role for macrophage-derived myeloperoxidase in the atherogenic process." | 1.32 | A taurine-supplemented vegan diet may blunt the contribution of neutrophil activation to acute coronary events. ( McCarty, MF, 2004) |
| "When taurine was added to the perfusion solution after ischemia, the plexus density increased about 2." | 1.28 | [The effect of taurine on the density of adrenergic nerve endings and the recovery of cardiac function after ischemia]. ( Pukhova, TM; Zhuchkova, NI, 1991) |
| "The taurine content was estimated from blood platelets and from the right atrial appendage removed during open heart surgery in 43 patients suffering from ischaemic heart disease." | 1.26 | Taurine in human auricular myocardium and blood platelets. ( Himberg, JJ; Merikallio, E; Paasonen, MK; Penttilä, O; Siltanen, P; Solatunturi, E, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (60.87) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wójcik, OP | 2 |
| Koenig, KL | 2 |
| Zeleniuch-Jacquotte, A | 2 |
| Costa, M | 2 |
| Chen, Y | 2 |
| Pearte, C | 1 |
| Kinscherf, R | 1 |
| Cafaltzis, K | 1 |
| Röder, F | 1 |
| Hildebrandt, W | 1 |
| Edler, L | 1 |
| Deigner, HP | 1 |
| Breitkreutz, R | 1 |
| Feussner, G | 1 |
| Kreuzer, J | 1 |
| Werle, E | 1 |
| Michel, G | 1 |
| Metz, J | 1 |
| Dröge, W | 1 |
| Obeid, OA | 1 |
| Johnston, K | 1 |
| Emery, PW | 1 |
| McCarty, MF | 2 |
| Yamori, Y | 1 |
| Murakami, S | 1 |
| Ikeda, K | 1 |
| Nara, Y | 1 |
| Kramer, JH | 1 |
| Chovan, JP | 1 |
| Schaffer, SW | 2 |
| Paasonen, MK | 1 |
| Penttilä, O | 1 |
| Merikallio, E | 1 |
| Siltanen, P | 1 |
| Himberg, JJ | 1 |
| Solatunturi, E | 1 |
| Nathan, RD | 1 |
| Crass, MF | 3 |
| Elizarova, EP | 1 |
| Lombardini, JB | 2 |
| Azuma, J | 2 |
| Sawamura, A | 2 |
| Awata, N | 2 |
| Pukhova, TM | 1 |
| Zhuchkova, NI | 1 |
| Allo, S | 1 |
| Mozaffari, M | 1 |
| Molaparast-Saless, F | 1 |
| Nellis, SH | 1 |
| Liedkte, AJ | 1 |
| Regitz, V | 1 |
| Paulson, DJ | 1 |
| Noonan, J | 1 |
| Fleck, E | 1 |
| Shug, AL | 1 |
| Pacifici, L | 1 |
| Botarelli, M | 1 |
| Cantagallo, A | 1 |
| Ramacci, MT | 1 |
| Maccari, F | 1 |
| Angelucci, L | 1 |
| Ohta, H | 1 |
| Hamaguchi, T | 1 |
| Harada, H | 1 |
| Takihara, K | 1 |
| Hasegawa, H | 1 |
| Yamagami, T | 1 |
| Ishiyama, T | 1 |
| De Lorenzi, F | 1 |
| Nigro, G | 1 |
| Comi, LI | 1 |
| Loiudice, A | 1 |
| Petretta, V | 1 |
| De Rango, F | 1 |
| Del Corso, P | 1 |
2 reviews available for taurine and Coronary Disease
| Article | Year |
|---|---|
The potential protective effects of taurine on coronary heart disease.
Topics: Animals; Coronary Disease; Humans; Taurine | 2010 |
Fish and lifestyle-related disease prevention: experimental and epidemiological evidence for anti-atherogenic potential of taurine.
Topics: Animals; Antioxidants; Atherosclerosis; Cholesterol 7-alpha-Hydroxylase; Coronary Disease; Diet; Fis | 2004 |
2 trials available for taurine and Coronary Disease
| Article | Year |
|---|---|
Usefulness of taurine in chronic congestive heart failure and its prospective application.
Topics: Administration, Oral; Cardiomyopathy, Dilated; Chronic Disease; Coenzymes; Coronary Disease; Double- | 1992 |
Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial.
Topics: Administration, Oral; Aged; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Th | 1985 |
19 other studies available for taurine and Coronary Disease
| Article | Year |
|---|---|
Serum taurine and risk of coronary heart disease: a prospective, nested case-control study.
Topics: Adult; Aged; Animals; Case-Control Studies; Cholesterol; Coronary Disease; Diet; Dietary Fats; Dieta | 2013 |
Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects.
Topics: Amino Acids; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cysteine; Disulfides | 2003 |
Plasma taurine and cysteine levels following an oral methionine load: relationship with coronary heart disease.
Topics: Adult; Case-Control Studies; Coronary Disease; Cysteine; Europe; Fasting; Humans; India; Male; Methi | 2004 |
A taurine-supplemented vegan diet may blunt the contribution of neutrophil activation to acute coronary events.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Clinical Trials as Topic; Coronary Disease; Diet, Veg | 2004 |
An expanded concept of "insurance" supplementation--broad-spectrum protection from cardiovascular disease.
Topics: Antihypertensive Agents; Arrhythmias, Cardiac; Blood Platelets; Coronary Disease; Energy Metabolism; | 1981 |
Effect of taurine on calcium paradox and ischemic heart failure.
Topics: Adenosine Triphosphatases; Animals; Calcium; Coronary Disease; Heart Failure; In Vitro Techniques; M | 1981 |
Taurine in human auricular myocardium and blood platelets.
Topics: Adult; Blood Platelets; Coronary Disease; Female; Heart Atria; Heart Diseases; Heart Failure; Heart | 1982 |
Electrophysiological effects of taurine in cardiac Purkinje fibers and myocardial taurine loss during ischemia. Is there a relationship?
Topics: Amino Acids; Animals; Coronary Disease; Dogs; Electrocardiography; Electrophysiology; Heart Conducti | 1981 |
Effects of taurine on calcium in platelets and their aggregation.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Calcium; Coronary Disease; Cytosol; Female; Humans; H | 1996 |
Release of tissue taurine from the oxygen-deficient perfused rat heart.
Topics: Animals; Coronary Disease; Hypoxia; In Vitro Techniques; Male; Myocardium; Perfusion; Rats; Taurine; | 1978 |
Loss of cardiac muscle taurine after acute left ventricular ischemia.
Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Electrocardiography; Female; Heart Rate; Male; Myoc | 1977 |
[The effect of taurine on the density of adrenergic nerve endings and the recovery of cardiac function after ischemia].
Topics: Adrenergic Fibers; Animals; Coronary Disease; Guinea Pigs; Heart; In Vitro Techniques; Myocardial Co | 1991 |
Potentiation of myocardial ischemic injury by drug-induced taurine depletion.
Topics: Adenine Nucleotides; Alanine; Animals; beta-Alanine; Coronary Disease; Heart; Male; Myocardium; Phos | 1987 |
The effects of propionylcarnitine taurine on cardiac performance in aerobic and ischemic myocardium.
Topics: Animals; Carnitine; Coronary Disease; Heart; Oxygen; Perfusion; Swine; Taurine | 1988 |
Protection of the ischemic myocardium by propionylcarnitine taurine amide. Comparison with other carnitine derivatives.
Topics: Animals; Carnitine; Coronary Disease; Hemodynamics; Male; Myocardium; Rats; Rats, Inbred Strains; Ta | 1987 |
[Effect of taurine amide derivatives on post-ischemic myocardial recovery in the working heart model in the rat].
Topics: Animals; Blood Pressure; Carnitine; Coronary Circulation; Coronary Disease; Male; Models, Cardiovasc | 1986 |
[Action of a taurine-nucleotide-vitamin association on carbohydrate metabolism].
Topics: Adult; Aged; Arteriosclerosis; Biliary Tract Diseases; Carbohydrate Metabolism; Coronary Disease; Di | 1971 |
[Taurine in the treatment of ischemic cardiopathies and of progressive muscular dystrophy].
Topics: Arteriosclerosis; Coronary Disease; Diabetic Angiopathies; Electrocardiography; Humans; Muscular Dys | 1971 |
[Electrocardiographic changes induced by taurine in coronary cardiopathies].
Topics: Adult; Aged; Coronary Disease; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; T | 1968 |